Global Drug Repurposing Serveice Market Research Report 2025(Status and Outlook)

September 2025 | 100 pages | ID: GB9A80A45FFFEN
Bosson Research

Abstracts

Drug repurposing services are specialized offerings that identify new therapeutic applications for existing drugs, compounds, or biologics that have already undergone some level of clinical testing or regulatory approval, leveraging computational biology, AI-driven data mining, pharmacological profiling, and clinical trial redesign to accelerate development timelines, reduce risks and costs associated with traditional drug discovery, and address unmet medical needs more efficiently. These services typically integrate multi-omics data, real-world evidence, and patent landscapes to propose viable repositioning candidates, thereby creating value for pharmaceutical companies, biotechs, and investors by extending product lifecycles, optimizing R&D portfolios, and unlocking new revenue streams from shelved or underutilized assets.

The global Drug Repurposing Serveice market size was estimated at USD 450.0 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.50% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Drug Repurposing Serveice market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Drug Repurposing Serveice market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Drug Repurposing Serveice market.

Global Drug Repurposing Serveice Market: Market Segmentation Analysis


This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.

A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.

Key Company

Anaxomics Biotech SL
Biovista
Chemotargets
IQVIA
Eurofins DiscoverX
NUVISAN
CD ComputaBio

Market Segmentation (by Type)

Target-centric
Drug-centric
Disease-centric

Market Segmentation (by Application)

Cardiovascular Disorders
Central Nervous Disorders
Oncology
Others

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Drug Repurposing Serveice Market
Overview of the regional outlook of the Drug Repurposing Serveice Market:

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Drug Repurposing Serveice Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Drug Repurposing Serveice, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Drug Repurposing Serveice
1.2 Key Market Segments
  1.2.1 Drug Repurposing Serveice Segment by Type
  1.2.2 Drug Repurposing Serveice Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 DRUG REPURPOSING SERVEICE MARKET OVERVIEW

2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 DRUG REPURPOSING SERVEICE MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Drug Repurposing Serveice Product Life Cycle
3.3 Global Drug Repurposing Serveice Revenue Market Share by Company (2020-2025)
3.4 Drug Repurposing Serveice Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Drug Repurposing Serveice Company Headquarters, Area Served, Product Type
3.6 Drug Repurposing Serveice Market Competitive Situation and Trends
  3.6.1 Drug Repurposing Serveice Market Concentration Rate
  3.6.2 Global 5 and 10 Largest Drug Repurposing Serveice Players Market Share by Revenue
  3.6.3 Mergers & Acquisitions, Expansion

4 DRUG REPURPOSING SERVEICE VALUE CHAIN ANALYSIS

4.1 Drug Repurposing Serveice Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF DRUG REPURPOSING SERVEICE MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Drug Repurposing Serveice Market Porter's Five Forces Analysis

6 DRUG REPURPOSING SERVEICE MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Drug Repurposing Serveice Market Size Market Share by Type (2020-2025)
6.3 Global Drug Repurposing Serveice Market Size Growth Rate by Type (2021-2025)

7 DRUG REPURPOSING SERVEICE MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Drug Repurposing Serveice Market Size (M USD) by Application (2020-2025)
7.3 Global Drug Repurposing Serveice Sales Growth Rate by Application (2020-2025)

8 DRUG REPURPOSING SERVEICE MARKET SEGMENTATION BY REGION

8.1 Global Drug Repurposing Serveice Market Size by Region
  8.1.1 Global Drug Repurposing Serveice Market Size by Region
  8.1.2 Global Drug Repurposing Serveice Market Size Market Share by Region
8.2 North America
  8.2.1 North America Drug Repurposing Serveice Market Size by Country
  8.2.2 U.S.
  8.2.3 Canada
  8.2.4 Mexico
8.3 Europe
  8.3.1 Europe Drug Repurposing Serveice Market Size by Country
  8.3.2 Germany
  8.3.3 France
  8.3.4 U.K.
  8.3.5 Italy
  8.3.6 Spain
8.4 Asia Pacific
  8.4.1 Asia Pacific Drug Repurposing Serveice Market Size by Region
  8.4.2 China
  8.4.3 Japan
  8.4.4 South Korea
  8.4.5 India
  8.4.6 Southeast Asia
8.5 South America
  8.5.1 South America Drug Repurposing Serveice Market Size by Country
  8.5.2 Brazil
  8.5.3 Argentina
  8.5.4 Columbia
8.6 Middle East and Africa
  8.6.1 Middle East and Africa Drug Repurposing Serveice Market Size by Region
  8.6.2 Saudi Arabia
  8.6.3 UAE
  8.6.4 Egypt
  8.6.5 Nigeria
  8.6.6 South Africa

9 KEY COMPANIES PROFILE

9.1 Anaxomics Biotech SL
  9.1.1 Anaxomics Biotech SL Basic Information
  9.1.2 Anaxomics Biotech SL Drug Repurposing Serveice Product Overview
  9.1.3 Anaxomics Biotech SL Drug Repurposing Serveice Product Market Performance
  9.1.4 Anaxomics Biotech SL SWOT Analysis
  9.1.5 Anaxomics Biotech SL Business Overview
  9.1.6 Anaxomics Biotech SL Recent Developments
9.2 Biovista
  9.2.1 Biovista Basic Information
  9.2.2 Biovista Drug Repurposing Serveice Product Overview
  9.2.3 Biovista Drug Repurposing Serveice Product Market Performance
  9.2.4 Biovista SWOT Analysis
  9.2.5 Biovista Business Overview
  9.2.6 Biovista Recent Developments
9.3 Chemotargets
  9.3.1 Chemotargets Basic Information
  9.3.2 Chemotargets Drug Repurposing Serveice Product Overview
  9.3.3 Chemotargets Drug Repurposing Serveice Product Market Performance
  9.3.4 Chemotargets SWOT Analysis
  9.3.5 Chemotargets Business Overview
  9.3.6 Chemotargets Recent Developments
9.4 IQVIA
  9.4.1 IQVIA Basic Information
  9.4.2 IQVIA Drug Repurposing Serveice Product Overview
  9.4.3 IQVIA Drug Repurposing Serveice Product Market Performance
  9.4.4 IQVIA Business Overview
  9.4.5 IQVIA Recent Developments
9.5 Eurofins DiscoverX
  9.5.1 Eurofins DiscoverX Basic Information
  9.5.2 Eurofins DiscoverX Drug Repurposing Serveice Product Overview
  9.5.3 Eurofins DiscoverX Drug Repurposing Serveice Product Market Performance
  9.5.4 Eurofins DiscoverX Business Overview
  9.5.5 Eurofins DiscoverX Recent Developments
9.6 NUVISAN
  9.6.1 NUVISAN Basic Information
  9.6.2 NUVISAN Drug Repurposing Serveice Product Overview
  9.6.3 NUVISAN Drug Repurposing Serveice Product Market Performance
  9.6.4 NUVISAN Business Overview
  9.6.5 NUVISAN Recent Developments
9.7 CD ComputaBio
  9.7.1 CD ComputaBio Basic Information
  9.7.2 CD ComputaBio Drug Repurposing Serveice Product Overview
  9.7.3 CD ComputaBio Drug Repurposing Serveice Product Market Performance
  9.7.4 CD ComputaBio Business Overview
  9.7.5 CD ComputaBio Recent Developments

10 DRUG REPURPOSING SERVEICE MARKET FORECAST BY REGION

10.1 Global Drug Repurposing Serveice Market Size Forecast
10.2 Global Drug Repurposing Serveice Market Forecast by Region
  10.2.1 North America Market Size Forecast by Country
  10.2.2 Europe Drug Repurposing Serveice Market Size Forecast by Country
  10.2.3 Asia Pacific Drug Repurposing Serveice Market Size Forecast by Region
  10.2.4 South America Drug Repurposing Serveice Market Size Forecast by Country
  10.2.5 Middle East and Africa Forecasted Sales of Drug Repurposing Serveice by Country

11 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)

11.1 Global Drug Repurposing Serveice Market Forecast by Type (2026-2033)
11.2 Global Drug Repurposing Serveice Market Forecast by Application (2026-2033)

12 CONCLUSION AND KEY FINDINGS

List Of Tables

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Drug Repurposing Serveice Market Size Comparison by Region (M USD)
Table 5. Global Drug Repurposing Serveice Revenue (M USD) by Company (2020-2025)
Table 6. Global Drug Repurposing Serveice Revenue Share by Company (2020-2025)
Table 7. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Repurposing Serveice as of 2024)
Table 8. Drug Repurposing Serveice Company Headquarters and Area Served
Table 9. Company Drug Repurposing Serveice Product Type
Table 10. Global Drug Repurposing Serveice Company Market Concentration Ratio (CR5 and HHI)
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. Midstream Market Analysis
Table 13. Downstream Customer Analysis
Table 14. Key Development Trends
Table 15. Driving Factors
Table 16. Drug Repurposing Serveice Market Challenges
Table 17. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 18. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 19. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 20. Global Drug Repurposing Serveice Market Size by Type (M USD)
Table 21. Global Drug Repurposing Serveice Market Size (M USD) by Type (2020-2025)
Table 22. Global Drug Repurposing Serveice Market Size Share by Type (2020-2025)
Table 23. Global Drug Repurposing Serveice Market Size Growth Rate by Type (2021-2025)
Table 24. Global Drug Repurposing Serveice Market Size by Application
Table 25. Global Drug Repurposing Serveice Market Size by Application (2020-2025) & (M USD)
Table 26. Global Drug Repurposing Serveice Market Share by Application (2020-2025)
Table 27. Global Drug Repurposing Serveice Sales Growth Rate by Application (2020-2025)
Table 28. Global Drug Repurposing Serveice Market Size by Region (2020-2025) & (M USD)
Table 29. Global Drug Repurposing Serveice Market Size Market Share by Region (2020-2025)
Table 30. North America Drug Repurposing Serveice Market Size by Country (2020-2025) & (M USD)
Table 31. Europe Drug Repurposing Serveice Market Size by Country (2020-2025) & (M USD)
Table 32. Asia Pacific Drug Repurposing Serveice Market Size by Region (2020-2025) & (M USD)
Table 33. South America Drug Repurposing Serveice Market Size by Country (2020-2025) & (M USD)
Table 34. Middle East and Africa Drug Repurposing Serveice Market Size by Region (2020-2025) & (M USD)
Table 35. Anaxomics Biotech SL Basic Information
Table 36. Anaxomics Biotech SL Drug Repurposing Serveice Product Overview
Table 37. Anaxomics Biotech SL Drug Repurposing Serveice Revenue (M USD) and Gross Margin (2020-2025)
Table 38. Anaxomics Biotech SL SWOT Analysis
Table 39. Anaxomics Biotech SL Business Overview
Table 40. Anaxomics Biotech SL Recent Developments
Table 41. Biovista Basic Information
Table 42. Biovista Drug Repurposing Serveice Product Overview
Table 43. Biovista Drug Repurposing Serveice Revenue (M USD) and Gross Margin (2020-2025)
Table 44. Biovista SWOT Analysis
Table 45. Biovista Business Overview
Table 46. Biovista Recent Developments
Table 47. Chemotargets Basic Information
Table 48. Chemotargets Drug Repurposing Serveice Product Overview
Table 49. Chemotargets Drug Repurposing Serveice Revenue (M USD) and Gross Margin (2020-2025)
Table 50. Chemotargets SWOT Analysis
Table 51. Chemotargets Business Overview
Table 52. Chemotargets Recent Developments
Table 53. IQVIA Basic Information
Table 54. IQVIA Drug Repurposing Serveice Product Overview
Table 55. IQVIA Drug Repurposing Serveice Revenue (M USD) and Gross Margin (2020-2025)
Table 56. IQVIA Business Overview
Table 57. IQVIA Recent Developments
Table 58. Eurofins DiscoverX Basic Information
Table 59. Eurofins DiscoverX Drug Repurposing Serveice Product Overview
Table 60. Eurofins DiscoverX Drug Repurposing Serveice Revenue (M USD) and Gross Margin (2020-2025)
Table 61. Eurofins DiscoverX Business Overview
Table 62. Eurofins DiscoverX Recent Developments
Table 63. NUVISAN Basic Information
Table 64. NUVISAN Drug Repurposing Serveice Product Overview
Table 65. NUVISAN Drug Repurposing Serveice Revenue (M USD) and Gross Margin (2020-2025)
Table 66. NUVISAN Business Overview
Table 67. NUVISAN Recent Developments
Table 68. CD ComputaBio Basic Information
Table 69. CD ComputaBio Drug Repurposing Serveice Product Overview
Table 70. CD ComputaBio Drug Repurposing Serveice Revenue (M USD) and Gross Margin (2020-2025)
Table 71. CD ComputaBio Business Overview
Table 72. CD ComputaBio Recent Developments
Table 73. Global Drug Repurposing Serveice Market Size Forecast by Region (2026-2033) & (M USD)
Table 74. North America Drug Repurposing Serveice Market Size Forecast by Country (2026-2033) & (M USD)
Table 75. Europe Drug Repurposing Serveice Market Size Forecast by Country (2026-2033) & (M USD)
Table 76. Asia Pacific Drug Repurposing Serveice Market Size Forecast by Region (2026-2033) & (M USD)
Table 77. South America Drug Repurposing Serveice Market Size Forecast by Country (2026-2033) & (M USD)
Table 78. Middle East and Africa Drug Repurposing Serveice Market Size Forecast by Country (2026-2033) & (M USD)
Table 79. Global Drug Repurposing Serveice Market Size Forecast by Type (2026-2033) & (M USD)
Table 80. Global Drug Repurposing Serveice Market Size Forecast by Application (2026-2033) & (M USD)

List Of Figures

LIST OF FIGURES

Figure 1. Industry Chain of Drug Repurposing Serveice
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Drug Repurposing Serveice Market Size (M USD), 2024-2033
Figure 5. Global Drug Repurposing Serveice Market Size (M USD) (2020-2033)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Drug Repurposing Serveice Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global Drug Repurposing Serveice Product Life Cycle
Figure 12. Global Drug Repurposing Serveice Revenue Share by Company in 2024
Figure 13. Drug Repurposing Serveice Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 14. The Global 5 and 10 Largest Players: Market Share by Drug Repurposing Serveice Revenue in 2024
Figure 15. Value Chain Map of Drug Repurposing Serveice
Figure 16. Global Drug Repurposing Serveice Market PEST Analysis
Figure 17. Global Drug Repurposing Serveice Market Porter's Five Forces Analysis
Figure 18. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 19. Global Drug Repurposing Serveice Market Share by Type
Figure 20. Market Size Share of Drug Repurposing Serveice by Type (2020-2025)
Figure 21. Market Size Share of Drug Repurposing Serveice by Type in 2024
Figure 22. Global Drug Repurposing Serveice Market Size Growth Rate by Type (2021-2025)
Figure 23. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 24. Global Drug Repurposing Serveice Market Share by Application
Figure 25. Global Drug Repurposing Serveice Market Share by Application (2020-2025)
Figure 26. Global Drug Repurposing Serveice Market Share by Application in 2024
Figure 27. Global Drug Repurposing Serveice Sales Growth Rate by Application (2020-2025)
Figure 28. Global Drug Repurposing Serveice Market Size Market Share by Region (2020-2025)
Figure 29. North America Drug Repurposing Serveice Market Size and Growth Rate (2020-2025) & (M USD)
Figure 30. North America Drug Repurposing Serveice Market Size Market Share by Country in 2024
Figure 31. U.S. Drug Repurposing Serveice Market Size and Growth Rate (2020-2025) & (M USD)
Figure 32. Canada Drug Repurposing Serveice Market Size (M USD) and Growth Rate (2020-2025)
Figure 33. Mexico Drug Repurposing Serveice Market Size (M USD) and Growth Rate (2020-2025)
Figure 34. Europe Drug Repurposing Serveice Market Size and Growth Rate (2020-2025) & (M USD)
Figure 35. Europe Drug Repurposing Serveice Market Share by Country in 2024
Figure 36. Germany Drug Repurposing Serveice Market Size and Growth Rate (2020-2025) & (M USD)
Figure 37. France Drug Repurposing Serveice Market Size and Growth Rate (2020-2025) & (M USD)
Figure 38. U.K. Drug Repurposing Serveice Market Size and Growth Rate (2020-2025) & (M USD)
Figure 39. Italy Drug Repurposing Serveice Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Spain Drug Repurposing Serveice Market Size and Growth Rate (2020-2025) & (M USD)
Figure 41. Asia Pacific Drug Repurposing Serveice Market Size and Growth Rate (M USD)
Figure 42. Asia Pacific Drug Repurposing Serveice Market Size Market Share by Region in 2024
Figure 43. China Drug Repurposing Serveice Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. Japan Drug Repurposing Serveice Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. South Korea Drug Repurposing Serveice Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. India Drug Repurposing Serveice Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Southeast Asia Drug Repurposing Serveice Market Size and Growth Rate (2020-2025) & (M USD)
Figure 48. South America Drug Repurposing Serveice Market Size and Growth Rate (M USD)
Figure 49. South America Drug Repurposing Serveice Market Size Market Share by Country in 2024
Figure 50. Brazil Drug Repurposing Serveice Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Argentina Drug Repurposing Serveice Market Size and Growth Rate (2020-2025) & (M USD)
Figure 52. Columbia Drug Repurposing Serveice Market Size and Growth Rate (2020-2025) & (M USD)
Figure 53. Middle East and Africa Drug Repurposing Serveice Market Size and Growth Rate (M USD)
Figure 54. Middle East and Africa Drug Repurposing Serveice Market Size Market Share by Region in 2024
Figure 55. Saudi Arabia Drug Repurposing Serveice Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. UAE Drug Repurposing Serveice Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. Egypt Drug Repurposing Serveice Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. Nigeria Drug Repurposing Serveice Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. South Africa Drug Repurposing Serveice Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Global Drug Repurposing Serveice Market Size Forecast (2020-2033) & (M USD)
Figure 61. Global Drug Repurposing Serveice Market Share Forecast by Type (2026-2033)
Figure 62. Global Drug Repurposing Serveice Market Share Forecast by Application (2026-2033)